SAMPLE REQUEST FORMS
Click here to download the form.
IMPORTANT SAFETY INFORMATION
Topical corticosteroids are indicated for the relief of inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses. Topical corticosteroids are contraindicated in those patients with a history of hypersensitivity to any of the components of the preparation. Use may produce reversible hypothalamic-pituitary-adrenal (HPA) axis suppression. May cause local adverse reactions including burning, itching, irritation, and dryness.
Pregnancy: Teratogenic Effects: Pregnancy Category C
CLICK HERE FOR FULL PRESCRIBING INFORMATION ABOUT ANALPRAM HC® CREAM 2.5%.
You are encouraged to report side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.
Topical corticosteroids are indicated for the relief of inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses. Topical corticosteroids are contraindicated in those patients with a history of hypersensitivity to any of the components of the preparation. Use may produce reversible hypothalamic-pituitary-adrenal (HPA) axis suppression. May cause local adverse reactions including burning, itching, irritation, and dryness.
Pregnancy: Teratogenic Effects: Pregnancy Category C
CLICK HERE FOR FULL PRESCRIBING INFORMATION ABOUT ANALPRAM HC® CREAM 2.5%.
You are encouraged to report side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.
CLICK HERE FOR FULL PRESCRIBING INFORMATION ABOUT ANALPRAM HC® CREAM 2.5%.
Click here to download the form.
INDICATIONS AND USAGE: NAFTIN (Naftifine HCl) GEL 2% is an allylamine antifungal indicated for the treatment of interdigital tinea pedis caused by the organisms Trichophyton rubrum, Trichophyton mentagrophytes, and Epidermophyton floccosum in patients 12 years of age and older.
IMPORTANT SAFETY INFORMATION
ADVERSE REACTIONS: In clinical trials with NAFTIN GEL 2%, the most common adverse reactions (2%) were application site reactions.
WARNINGS AND PRECAUTIONS: If redness or irritation develops with the use of NAFTIN GEL 2%, treatment should be discontinued.
Please click here for full Prescribing Information about NAFTIN GEL 2%.